UBS Group
BCDA icon

UBS Group’s BioCardia BCDA Stock Holding History

UBS Group’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,423
Closed -$5.53K – 10490
2025
Q4 		$5.53K Sell
4,423
-6,317
-59% -$8.58K ﹤0.01% 8669
2025
Q3 		$13.9K Buy
10,740
+6,561
+157% +$12.8K ﹤0.01% 8384
2025
Q2 		$8.15K Sell
4,179
-423
-9% -$941 ﹤0.01% 8974
2025
Q1 		$11.7K Sell
4,602
-148
-3% -$358 ﹤0.01% 8536
2024
Q4 		$10.4K Buy
+4,750
New +$11.1K ﹤0.01% 8303
2023
Q3 		– Sell
-41
Closed -$1.64K – 9454
2023
Q2 		$1.64K Sell
41
-29
-41% -$894 ﹤0.01% 7881
2023
Q1 		$2.04K Sell
70
-453
-87% -$15K ﹤0.01% 8597
2022
Q4 		$16.4K Buy
523
+404
+339% +$11.5K ﹤0.01% 7908
2022
Q3 		$3K Sell
119
-213
-64% -$5.51K ﹤0.01% 9514
2022
Q2 		$7K Buy
332
+219
+194% +$5.24K ﹤0.01% 8453
2022
Q1 		$4K Sell
113
-275
-71% -$8.17K ﹤0.01% 9270
2021
Q4 		$11K Buy
+388
New +$14.2K ﹤0.01% 8657
2021
Q3 		– Sell
-250
Closed -$15K – 9527
2021
Q2 		$15K Buy
+250
New +$15.2K ﹤0.01% 7636
2021
Q1 		– Sell
-290
Closed -$15K – 8991
2020
Q4 		$15K Buy
+290
New +$11.6K ﹤0.01% 7150
2020
Q2 		– Sell
-17
Closed -$1K – 7934
2020
Q1 		$1K Sell
17
-173
-91% -$10.7K ﹤0.01% 7732
2019
Q4 		$10K Buy
+190
New +$11.2K ﹤0.01% 7273

Other funds holding BCDA

CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PP
Pingora Partners Wilson, Wyoming $169M AUM 56.08% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group's BCDA Position: Q1 2026 in Review

UBS Group sold out of BioCardia (BCDA) in Q1 2026, closing a stake of 4,423 shares — an estimated $5.53K sold.

UBS Group first reported a position in BCDA in Q4 2019 and held it in 16 quarters. The position peaked at $16.4K in Q4 2022. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.

  • UBS Group reported no remaining BioCardia position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 4,423 BioCardia shares in Q1 2026, an estimated $5.53K.
  • UBS Group first reported a position in BioCardia in Q4 2019 and held it in 16 quarters.
  • UBS Group's BioCardia position peaked at $16.4K in Q4 2022.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.